Project support for a Phase 1 clinical trial of new broadly neutralizing anti-HIV monoclonal antibodies (bnAbs) to assess their safety and potential to prevent vertical HIV transmission in infants 

Project support for a phase 3 clinical trial to demonstrate the efficacy of a shortened treatment regimen for children with TB

Project support for a clinical study to evaluate the use of a variety of rapid diagnostic tools to detect TB in high-risk children in the Eastern Cape

Project support for the Phase 1 clinical trial of a novel HIV vaccine for infants with perinatal HIV exposure who are HIV negative at birth

Project support to finalize a four-year collaborative study to understand the effects of HIV on the central nervous system and the development of lymphatic reservoirs in children and adolescents, to enable future HIV cure efforts 

Project support to develop manufacturing technology for anti-retroviral active pharmaceutical ingredients to localize the production of key HIV products

Project support to sustain access to care for key and priority populations with a focus on HIV prevention

Project support to sustain access to care for key and priority populations, with a focus on HIV prevention

Project support to sustain access to care for key and priority populations, with a focus on HIV prevention

Project support to strengthen the capacity of the National Department of Health as it responds to the immediate HIV service delivery crisis and plans for the integration of HIV services into Primary Health Care

Project support to sustain essential HIV services and retain 155,484 people living with HIV in care through technical support and financial assistance to five high-burden districts in Rwenzori and Bunyoro regions

Project support to sustain essential HIV services and retain 218,181 people living with HIV in care through technical assistance to districts, in-service training, and mentorship of health workers

Project support to sustain HIV essential services and retain 589,181 people living with HIV in care, and strengthen primary health care structures to deliver integrated HIV prevention and care services in 72 districts in seven regions

Project support to the management of WHO's Global Accelerator for Pediatric Formulations (GAP-f) network, which is focused on accelerating access to safe, effective, quality, affordable pediatric medicines

General support to an organization that strengthens pediatric and adolescent HIV service delivery by providing technical support and accelerated access to optimal pediatric formulations in high-burden countries

General support for an organization providing technical assistance to governments and partners to implement a peer-led service delivery model supporting children and adolescents living with HIV